Literature DB >> 5066992

Cardiohemodynamic effects of BAY a 1040 in the dog.

K Hashimoto, N Taira, S Chiba, K Hashimoto, M Endo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5066992

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  7 in total

1.  Abolition by calcium antagonists of the autoregulation of renal blood flow.

Authors:  H Ono; H Kokubun; K Hashimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

2.  Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy.

Authors:  K Landmark; S Sire; E Thaulow; J P Amlie; S Nitter-Hauge
Journal:  Br Heart J       Date:  1982-07

3.  Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog.

Authors:  A Narimatsu; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-08       Impact factor: 3.000

4.  Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.

Authors:  Y Wada; K Satoh; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

5.  Effects of nifedipine, a potent calcium-antagonistic coronary vasodilator, on atrioventricular conduction and blood flow in the isolated atrioventricular node preparation of the dog.

Authors:  N Taira; A Narimatsu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

6.  Influence of glyceryl trinitrate on force of contraction and action potential of guinea-pig myocardium.

Authors:  M Korth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

7.  Effect of nifedipine on exercise tolerance in patients with angina pectoris.

Authors:  J H Atterhög; L G Ekelund; A L Melin
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.